Piotr Rutkowski

The Maria Sklodowska-Curie National Research Institute of Oncology

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma”.

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

New England Journal of Medicine(2015)10.1056/nejmoa1504030

N/A

1.3DataRank · unranked

8085 citations

Vanna Chiarion-Sileni, Rene Gonzalez, Jean Jacques Grob, C. Lance Cowey, Christopher D. Lao +35 more

Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib

Annals of Oncology(2023)10.1016/j.annonc.2023.04.006

N/A

1.2DataRank · unranked

42 citations

Sebastian Bauer, David Gómez-Peregrina, Yoon‐Koo Kang, Robin L. Jones, Piotr Rutkowski +13 more

Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network

Annals of Oncology(2020)10.1016/j.annonc.2020.08.2232

N/A

0.749DataRank · unranked

146 citations

Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment

Melanoma Research(2023)10.1097/cmr.0000000000000885

N/A

0.563DataRank · unranked

14 citations

Karolina Piejko, Krzysztof Ostaszewski, Robert Dziura, Łukasz Galus, Barbara Ziółkowska +12 more

Porównanie pośrednie wyników leczenia chorych na zaawansowane/przerzutowe czerniaki za pomocą niwolumabu lub pembrolizumabu – analiza wieloośrodkowa

Oncology in Clinical Practice(2020)10.5603/ocp.2020.0037

N/A

0.104DataRank · unranked

1 citations

Marcin Ziętek, Grażyna Kamińska-Winciorek, Anna M. Czarnecka, Karolina Piejko, Łukasz Galus +9 more

Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities

Cancer(2021)10.1002/cncr.33618

N/A

0DataRank · unranked

229 citations

Anna Maria Frezza, Jean‐Yves Blay, Elizabeth H. Baldini, Sylvie Bonvalot, Judith V.M.G. Bovée +52 more

Novel trial designs for patients with gastrointestinal stromal tumor

ESMO Open(2024)10.1016/j.esmoop.2023.102218

N/A

0DataRank · unranked

3 citations

S. Rothschild, Guillermo Villacampa, Michael C. Heinrich, Sally L. George, Jean‐Yves Blay +10 more